Location: Home
  • search
  • go
  • Relate News
  • 3/11/2014Clinipace and Choice Pharma Merge to Strengthen Clinical Research Capa...
  • 3/11/2014WuXi PharmaTech and Pacific Biomarkers in Partnership for Clinical Res...
  • 3/11/2014Latest Executive Moves
  • 3/10/2014How China's Anti-Monopoly Laws Could Impact the Pharmaceutical Sector
  • 3/6/2014Chinese M&A Trended Down in February with Healthcare Deals in Lead
  • 3/5/2014What Money Failed To Buy: The Limits Of China's Healthcare Reform
  • 3/4/2014Executive Moves
  • 3/3/2014Improved Prescribing and Reimbursement Practices in Ningxia Pay-for-pe...
  • 3/2/2014CDE Review of Class 1 New Drug Applications Nearly Doubled in 2013
  • 3/2/2014Shanghai Pudong Seeks to Become CMO Trial Site
  • 3/2/2014Shanghai Anew Pharma Completes Preclinical Study of Oncology Drug Cand...
  • 2/27/2014NHFPC Vice Minister MA Xiaowei Meets PhRMA Delegation
  • 2/27/2014Guangzhou Pharmaceutical Group to Step Up Acquisitions for Accelerated...
  • 2/27/2014Shanxi Taxus Pharma to Acquire U.S. Medical Firm for US$5M
  • 2/27/2014Bayer to Acquire 100% of Chinese OTC Drug Player Dihon Pharma
  • 2/27/2014Hays: Life Sciences Jobs Flourishing in China's Emerging Healthcare Ma...
  • 2/27/2014SMEI: Chinese Pharma Saw Steady Growth in 2013 Despite Challenges (Upd...
  • 2/27/2014Chinese Foreign Trade of Medicines and Health Products Maintained Doub...
  • 2/26/2014Executive Moves
  • 2/25/2014Amcham: US Firms in China Still Optimistic About China Despite Challen...
  • 2/24/2014Chinese Pharma Saw 17.9% Growth in 2013
  • 2/21/2014MOFCOM Announces Its Simplified Merger-Review Program
  • 2/20/2014MNCs Dominate the Chinese Ophthalmology Drug Market
  • 2/17/2014Alibaba/CITIC Alliance: A Game Changer for Chinese Pharma e-Commerce
  • 2/14/2014EU Lifts Anti-dumpling Duties on API Dicyandiamide
  • 2/13/2014Zhejiang Plans Separation of Drug Sales and Medical Services in Level ...
  • 2/12/2014Data Snapshot: Top 10 Drugs in Representative Shanghai Hospitals 2013
  • 2/12/201416 Biopharma Cos Made "Forbes China 100 Most Potential Developmen...
  • 2/12/2014CDE Initiates Development of Technical Guidelines for Biosimilars
  • 2/12/2014Kangmei Enters Hospital Pharmacy Contract Management Deals Spanning Fo...
  • Page:227/334 Total number of articles:9993: [First][<<] [225] [226] [227] [228] [229] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group